Tony Wyss-Coray at ARDD2025: Circulatory biomarkers of brain aging

Tony Wyss-Coray at ARDD2025: Circulatory biomarkers of brain aging

by Tony Wyss-Coray

Life & Natural Systems Medicine & Health MFKHHuman growth and developmentMFKH3Maturation and ageing
🎙 Tony Wyss-Coray 👥 9K 📅 January 21, 2026 ⏱ 24 min 👁 533 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

brain agingbiomarkersCSFplasmasynaptic proteinsproteomicsAlzheimer's diseaseorgan agemachine learning

Summary

Tony Wyss-Coray presents his research on circulatory biomarkers of brain aging at the ARDD2025 conference. He begins by describing the structural and functional decline of the brain with age, noting that a third of centenarians retain intact cognition. He emphasizes the need for molecular understanding and introduces the Knight Initiative for Brain Resilience, which aims to create a comprehensive atlas of brain molecular changes. The talk focuses on identifying protein biomarkers in cerebrospinal fluid (CSF) and blood that track cognitive decline. In CSF, a ratio of two synaptic proteins predicts cognitive decline with a 15-fold hazard ratio difference. In blood, a similar synaptic protein signature, though less strong, predicts cognitive impairment and future decline. He highlights the Global Neurodegeneration Proteomics Consortium (GNPC) for enabling large-scale validation. He also discusses using the ratio of CSF-to-plasma protein levels to infer brain transport and genetic influences, such as vitamin B12 transport. Using machine learning, he shows that organ-specific aging signatures, particularly brain age, predict Alzheimer’s disease and mortality. He validates the brain origin of proteins using click chemistry in mice. He concludes that synaptic protein changes in CSF and blood are linked to cognitive function and can predict resilience and decline.

198 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation offers high value by introducing novel biomarkers for brain aging that are measurable in blood, which is less invasive than CSF. The argumentation is solid, supported by large datasets (e.g., 3,000 CSF samples, 50,000 UK Biobank participants) and advanced proteomic platforms. The speaker carefully explains the methodology, including multivariate regression and machine learning, and addresses potential limitations, such as the need for longitudinal validation. The use of multiple cohorts and cross-platform consistency strengthens the claims. However, some results are preliminary and not yet fully published, and the causal link between synaptic proteins and cognitive decline is inferred rather than proven.

Scientific Rigor, Source Quality, Title Accuracy

The talk is scientifically rigorous, with clear methodology and appropriate caveats. The speaker acknowledges ongoing work and the need for more data. The title accurately reflects the content. The sources cited include the Knight Initiative, the GNPC, and UK Biobank, which are credible. No external sources are explicitly referenced in the video, but the research is based on published and ongoing studies. The speaker also mentions collaborations with other researchers, adding to the credibility. The title is well-matched to the content, focusing on circulatory biomarkers of brain aging.

205 words

Title / Content Match

The title accurately reflects the content, which focuses on circulatory biomarkers of brain aging.

Quality & Reliability

8/10

Presentation of original research by a leading expert, with data from large cohorts and advanced proteomic methods. Some claims are preliminary and not yet fully published, but the methodology is robust and the results are consistent with existing literature.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • Knight Initiative for Brain Resilience — Mentioned as a major initiative supporting the brain atlas project.
  • Global Neurodegeneration Proteomics Consortium (GNPC) — Consortium providing large-scale plasma proteomic data for validation.
  • UK Biobank — Used for organ age prediction and mortality analysis.

Concurring Sources

  • Plasma proteomic signatures of brain aging — Related study on plasma biomarkers of brain aging.

Dissenting Sources

  • Potential limitations of blood-based biomarkers — Some studies question the specificity of blood-based biomarkers for brain-derived proteins.

Contribution & Novelties

The talk presents novel findings on synaptic protein biomarkers in CSF and blood that predict cognitive decline and brain aging. The use of CSF-to-plasma ratios to infer brain transport and genetic influences is innovative. The organ age prediction using machine learning and proteomics is a significant advance. The validation of brain-derived proteins using click chemistry in mice provides strong evidence for the origin of these biomarkers.

Pour aller plus loin :

115 words

Radar Profile

The radar profile shows high scores in quality and quantity of information, with a strong technical level and good reliability. The talk is dense with data and methodological detail, making it highly informative for a specialized audience.

Reliability 8/10

💬 No comments were provided for analysis.